Global Infectious Disease Biomarker Testing Market Growth (Status and Outlook) 2025-2031

According to this study, the global Infectious Disease Biomarker Testing market size will reach US$ million by 2031.

United States market for Infectious Disease Biomarker Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Infectious Disease Biomarker Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Infectious Disease Biomarker Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Infectious Disease Biomarker Testing players cover Abacus Diagnostica, ALPCO, Abbott Laboratories, Agilent Technologies, Becton, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Infectious Disease Biomarker Testing Industry Forecast” looks at past sales and reviews total world Infectious Disease Biomarker Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease Biomarker Testing sales for 2025 through 2031. With Infectious Disease Biomarker Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Biomarker Testing industry.

This Insight Report provides a comprehensive analysis of the global Infectious Disease Biomarker Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Biomarker Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Biomarker Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Biomarker Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Biomarker Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Biomarker Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
PCR
NGS
ELISA or EIA
IHC
ISH
Others

Segmentation by Application:
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific

Please note: The report will take approximately 2 business days to prepare and deliver. Show more